Trial intelligence / Profile preview

Contraceptive Efficacy of MK-8175A (NOMAC-E2)

NCT01656434Phase 3Terminated

Sponsor
Organon & Co.
Start
Nov 2012
Primary completion
Feb 2014
Modality
Small Molecules
01

Overview

Phase 3, randomised, open-label trial of nomegestrol and estradiol in pregnancy (2 arms), sponsored by Organon & Co. Primary endpoint: Number of In-Treatment Pregnancies Per 100 Woman Years of Exposure (Pearl Index) at 1 year. Started Nov 2012; status: terminated.

02

Drugs

nomegestrolestradiol
03

Conditions

pregnancy

Beyond the preview

Go deeper on NCT01656434.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01656434.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call